Israel HealthCare Ventures (IHCV) is an Israeli life sciences venture fund. To date, IHCV I and IHCV II have cumulatively invested approximately $135 million in 27 companies.
IHCVs portfolio includes companies in medical fields including cardiology, orthopedics, oncology, general surgery, gastroenterology, esthetics, central nervous system, and others. It covers therapeutic and diagnostic technologies as well as rehabilitation, drug delivery, and consumer healthcare. About 75% of the funds portfolio consists of medical device companies, with the rest in pharmaceuticals and biotechnology.
IHCV is a venture fund that operates much like a long-term investment company. It pursues a hands-on, personal, and informal approach, providing portfolio companies with professional advice, ongoing management support, and an extensive network of contacts throughout the global medical and financial arenas.
The fund is not limited by preset policies that define the stage, discipline, or size of investment.